1. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease
    Min Wang et al, 2020, Hepatology CrossRef
  2. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases
    Himangshu Sonowal et al, 2019, Oxidative Stress in Lung Diseases CrossRef
  3. Does the breakdown of the detoxification system for aldehydes as a result of aldose reductase upregulation lead to alcohol‐induced liver injury in humans and mice?
    Nigishi Hotta et al, 2020, Journal of Diabetes Investigation CrossRef
  4. Caulerpa lentillifera improves ethanol-induced liver injury and modulates the gut microbiota in rats
    Kuan-Yu Lin et al, 2023, Current Research in Food Science CrossRef
  5. Myricitrin ameliorates ethanol-induced steatosis in mouse AML12 liver cells by activating AMPK, and reducing oxidative stress and expression of inflammatory cytokines
    Jing Gao et al, 2018, Molecular Medicine Reports CrossRef
  6. Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis
    Xin Chi et al, 2024, Frontiers in Pharmacology CrossRef
  7. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis
    Chang Guo et al, 2018, Chemico-Biological Interactions CrossRef
  8. Hepatoprotective Effects of the Cichorium intybus Root Extract against Alcohol-Induced Liver Injury in Experimental Rats
    Jihee Kim et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
  9. Recent Progress on Fructose Metabolism—Chrebp, Fructolysis, and Polyol Pathway
    Katsumi Iizuka, 2023, Nutrients CrossRef
  10. Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats
    Yanming Bai et al, 2024, Frontiers in Pharmacology CrossRef
  11. Rosmarinic acid alleviates ethanol-induced lipid accumulation by repressing fatty acid biosynthesis
    Chang Guo et al, 2020, Food & Function CrossRef
  12. Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis
    Qing Li et al, 2023, Nutrients CrossRef
  13. Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview
    Longxin Qiu et al, 2019, BioMed Research International CrossRef
  14. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease
    Tong Wang et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
  15. Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity
    Yong Rao et al, 2019, British Journal of Pharmacology CrossRef
  16. The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism
    Chang Xian Li et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  17. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
    Richard J. Johnson et al, 2020, Frontiers in Aging Neuroscience CrossRef
  18. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
    Himangshu Sonowal et al, 2021, Current Medicinal Chemistry CrossRef